Skip to main content
. 2022 Apr 25;13:863959. doi: 10.3389/fphar.2022.863959

TABLE 2b.

Clinical observations—Male rats.

REL-1017 Methadone MK-801 p
Dose (mg/kg/d)
0 20 40 80 20 2
Number of animals 15 15 15 15 15 15 (MK801 vs. all)
Behaviour/activity
 Activity decreased
  Number of times recorded 0 0 0 0 0 40
  Number of animals affected 12 <0.0001
 Ataxia
  Number of times recorded 0 0 0 0 0 23
  Number of animals affected 13 <0.0001
 Salivation
  Number of times recorded 0 0 0 0 0 15
  Number of animals affected 12 <0.0001
 Trembling
  Number of times recorded 0 0 0 0 0 6
  Number of animals affected 5 <0.0001
 Ventral recumbency
  Number of times recorded 0 0 0 0 0 11
  Number of animals affected 9 <0.0001
External Appearance
 Limb function impaired
  Number of times recorded 0 0 0 0 0 62
  Number of animals affected 10 <0.0001
 Material around eyes, red
  Number of times recorded 0 0 0 0 0 4
  Number of animals affected 3 <0.001
 Material around nose, red
  Number of times recorded 0 0 1 0 0 0
  Number of animals affected 1 ns
Pelage/Skin
 Hair, sparse
  Number of times recorded 0 0 0 2 3 0
  Number of animals affected 1 1 ns
 Hair, wet
  Number of times recorded 0 0 0 0 0 6
  Number of animals affected 6 <0.0001
 Scabbed area
  Number of times recorded 0 0 1 0 0 0
  Number of animals affected 1 ns